Session Information
2012 Midyear Clinical Meeting
Click here to go to the previous page
A Compounding Tragedy - A National Response
Track:
Education Sessions (CE)
Program Code: 275-L03
Date: Wednesday, December 5, 2012
Time: 8:00 AM to 9:30 AM EST
Location:
Breakers C, Level 2, South Convention Center
PRESENTER:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Christopher Topoleski, BA, Director, Federal Regulatory Affairs, American Society of Health-System Pharmacists
PROGRAM CHAIR:
JoAnn Harris
Description
This session will provide an update from ASHP, federal officials, and other experts on emerging developments related to preventing contaminated drug products from entering the drug supply chain.
LEARNER OUTCOMES:
- Describe the activities that ASHP has initiated in response to the recent compounding tragedy to meet member needs.
- Discuss potential follow-up actions from state boards of pharmacy.
- Discuss the role of the FDA in pharmacy compounding and manufacturing.
- Discuss ways ASHP has taken the lead to ensure the quality of the sterile compounded products.
- Distinguish the difference between pharmacy compounding and manufacturing.
This session is a part of: